Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Martin Shkreli Refuses to Answer Lawmakers’ Questions About 5,000% Drug Price Hike

HeadlineFeb 05, 2016

In other news from the pharmaceutical industry, the former hedge fund manager dubbed “the most hated man in America” after he hiked the price of a life-saving drug by more than 5,000 percent has refused to testify before Congress. Martin Shkreli founded Turing Pharmaceuticals, which purchased the drug Daraprim and boosted the price from $13.50 to $750. He was questioned Thursday by members of a House committee, including Utah Congressmember Jason Chaffetz.

Rep. Jason Chaffetz: “What do you say to that single pregnant woman who might have AIDS, no income, and she needs Daraprim in order to survive? What do you say to her when she has to make that choice? What do you say to her?”

Martin Shkreli: “On the advice of counsel, I invoke my Fifth Amendment privilege against self-incrimination and respectfully decline to answer your question.”

After refusing to answer any questions, Martin Shkreli took to Twitter, writing, “Hard to accept that these imbeciles represent the people in our government.” Shkreli is out on $5 million bail on unrelated charges of cheating hedge fund investors.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top